Clinical Trials Browser

Phase 2 × Breast Neoplasms × penpulimab × Clear all

NCT05726175 2023-02-13

Disitamab Vedotin(RC48) Combined With Penpulimab(AK105) for Neoadjuvant Treatment of HER2-low Breast Cancer

Phase 2 Unknown

Breast Neoplasms